CompletedNot Applicable

New-Onset Atrial Fibrillation Complicating Acute Myocardial Infarction in China

China832 participantsStarted 2023-03-01

Plain-language summary

To investigate the prognostic impacts of the atrial fibrillation burden (AFb) in acute myocardial infarction (AMI) patients who developed paroxysmal new-onset atrial fibrillation (NOAF) during the index AMI hospitalization.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients hospitalized for AMI including both STEMI and NSTEMI between January 2014 and January 2022 at the CCU department of Shanghai Tenth People's Hospital, KaiFeng Central Hospital, and the First Affiliated Hospital of Zhengzhou University.
✓. Patients who developed a first documented AF (NOAF) during the index AMI hospitalization；
✓. Adult patients (\>18 years old).

Exclusion criteria

✕. Patients with a medical history of pre-existing AF;
✕. Patients with a medical history of rheumatic valvular disease;
✕. Patients with a medical history of sick sinus syndrome;
✕. Patients undergoing emergent coronary artery bypass surgery;
✕. Patients' medical records with serious deficiencies and CEM data cannot be retrieved;

What they're measuring

All-cause death

Timeframe: From the time of AMI discharge until occurrence of an outcome of interest, death, or loss to follow up, maximum up to 10 years

Trial details

NCT IDNCT05511649

SponsorShanghai 10th People's Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-07-27

View on ClinicalTrials.gov More New Onset Atrial Fibrillation trials